Business
The Rhythm (ASX:RHY) share price surges on cancer testing milestone
The Rhythm Biosciences Ltd (ASX: RHY) share price has opened higher on Tuesday after the successful completion of Study 6 for its ColoSTAT product. At the time of writing, the Rhythm share price is trading at $1.60, up 6.33%.
Let’s take a closer look at this announcement and what it means for the Rhythm share price.
Why the Rhythm share price opened higher on Tuesday
The Rhythm share price has surged. Climbing from a low of 3.5 cents 12-months ago to a high of $1.675 on 2 March. The company continues to hit significant milestones. In particular, for the commercialisation of its simple, affordable, and effective ColoSTAT blood test….
-
Noosa News24 hours agoThe best new books released in August, from Toni Jordan, Rhett Davis and more
-
Business23 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares
-
Business21 hours agoHow to build a million-dollar ASX share portfolio in 25 years
-
General21 hours agoLabor’s socialist bedroom tax | The Spectator Australia